{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:18:11Z","timestamp":1752549491078},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/ftd.0000000000000264","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:33:21Z","timestamp":1448382801000},"page":"280-284","source":"Crossref","is-referenced-by-count":6,"title":["Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients"],"prefix":"10.1097","volume":"38","author":[{"given":"Nynke M.","family":"Kannegieter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nauras","family":"Shuker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Vafadari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem","family":"Weimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis A.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210129","first-page":"21","article-title":"Meuer S, et al..","volume":"24","author":"Sommerer","year":"2009","journal-title":"Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit Nephrol Dial Transplant"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/FTD.0b013e3181c0eecb","article-title":"Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives.","volume":"32","author":"van Rossum","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0966-3274(02)00024-2","article-title":"How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients.","volume":"9","author":"Klupp","year":"2002","journal-title":"Transpl Immunol"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/TP.0b013e318250fc62","article-title":". Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry.","volume":"93","author":"Vafadari","year":"2012","journal-title":"Transplantation"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2174\/1568026033451916","article-title":"Regulation of MAPK signaling pathways through Immunophilin-ligand Complex.","volume":"3","author":"Matsuda","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2165\/11593890-000000000-00000","article-title":". Once-versus twice-daily tacrolimus.","volume":"71","author":"Barraclough","year":"2011","journal-title":"Drugs"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/FTD.0000000000000136","article-title":". Conversion from twice-daily to once-daily tacrolimus does not reduce intra-patient variability in tacrolimus exposure.","volume":"37","author":"Shuker","year":"2015","journal-title":"Ther Drug Monit"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","article-title":". Single cell profiling of potentiated phospho-protein networks in Cancer cells.","volume":"118","author":"Irish","year":"2004","journal-title":"Cell"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1186\/2047-1440-1-20","article-title":". Phospho-specific flow cytometry for pharmacodynamic monitoring of immunosuppressive therapy in transplantation.","volume":"1","author":"Baan","year":"2012","journal-title":"Transplant Res"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":". Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.","volume":"10","author":"Kramer","year":"2010","journal-title":"Am J Transplant"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3182a203bd","article-title":". OSAKA trial: a randomized, Controlled trial comparing tacrolimus QD and BD in kidney transplantation.","volume":"96","author":"Albano","year":"2013","journal-title":"Transplantation"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1399-0012.2010.01377.x","article-title":". Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies.","volume":"25","author":"van Hooff","year":"2011","journal-title":"Clin Transplant"},{"key":"R13-13-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e318296c9d5","article-title":". Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.","volume":"96","author":"Tsuchiya","year":"2013","journal-title":"Transplantation"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/TP.0b013e3182098ff0","article-title":". Conversion from prograf to advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.","volume":"91","author":"Hougardy","year":"2011","journal-title":"Transplantation"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/TP.0b013e3182292426","article-title":". Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients.","volume":"92","author":"Wu","year":"2011","journal-title":"Transplantation"},{"key":"R16-13-20210129","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00467-013-2724-0","article-title":". Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study.","volume":"29","author":"Lapeyraque","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R17-13-20210129","first-page":"253","article-title":". The role of the p38 pathway in adaptive immunity.","volume":"4","author":"Cook","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"R18-13-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1034\/j.1600-6143.2003.00123.x","article-title":"T-cell allorecognition and transplant rejection: a summary and update.","volume":"3","author":"Heeger","year":"2003","journal-title":"Am J Transplant"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:30:05Z","timestamp":1620952205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201604000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000264","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}